# Actinium Pharmaceuticals, Inc.: Form D filings

Actinium Pharmaceuticals, Inc., a pharmaceuticals company in New York, NY, filed 3 Form D notices with the SEC between 2011 and 2012. The latest, on December 31, 2012, reports $5.1 million sold of a $15 million offering to 108 investors.

Find out what Actinium Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Actinium%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Actinium%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Factinium-pharmaceuticals-inc-1328440)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Actinium%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Actinium%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Factinium-pharmaceuticals-inc-1328440)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 501 Fifth Avenue, 3rd Floor, New York, NY, 10017
- Phone: (646) 459-4201
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1328440

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 31, 2012 | New notice | $15,000,000 | $5,141,450 | $9,858,550 | 108 | Dec 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1328440/000132844012000001/0001328440-12-000001-index.htm) |
| Nov 3, 2011 | New notice | $750,000 | $364,000 | $386,000 | 11 | Oct 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1328440/000132844011000005/0001328440-11-000005-index.htm) |
| Oct 17, 2011 | New notice | $6,000,000 | $4,125,025 | $1,874,975 | 65 | Oct 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1328440/000132844011000004/0001328440-11-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Sandesh V. Seth | Director |  |
| David V. Nicholson | Director |  |
| Dragan V. Cicic | Executive Officer |  |
| Enza V. Guagenti | Executive Officer |  |
| Jack V. Talley | Executive Officer, Director |  |
| Rosemary V. Mazanet | Director |  |
| Sergio V. Traversa | Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Dec 31, 2012](https://specstream.ai/data/form-d/week/2012-12-31) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Actinium Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).